Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice

Molecular Brain Research

Volumn 73, Issue 1-2, 1999, Pages 17-27

  Kim, Jae Il ^a   Ju, Won Kyu ^a   Choi, Jin Ho ^b   Kim, Jin ^c   Choi, Eun Kyoung ^a   Carp, Richard I ^d   Wisniewski, Henryk M ^d   Kim, Yong Sun ^a  

^a Hallym University   (South Korea)

^b Div of Food Sci and Biotechnology   (South Korea)

^c The Catholic University of Korea College of Medicine   (South Korea)

^d NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Astrocyte; Cytokine; NF B; Prion; Reactive oxygen species; Scrapie

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; GENE EXPRESSION; HIPPOCAMPUS; IMMUNOREACTIVITY; MOUSE; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RNA ANALYSIS; SCRAPIE; SCRAPIE AGENT; THALAMUS;

ANIMALS; BRAIN; CYTOKINES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-6; LYMPHOTOXIN-ALPHA; MALE; MICE; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SCRAPIE; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; SCRAPIE PRION;

EID: 0032721724     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(99)00229-6     Document Type: Article

References (70)

1. Akama K.T., Albanese C., Pestell R.G., Van Eldik L.J. Amyloid beta-peptide stimulates nitric oxide production in astrocytes through a NFkappaB-dependent mechanism. Proc. Natl. Acad. Sci. U.S.A. 95:1998;5795-5800.
2. Baeuerle P.A. The inducible transcription factor NF-κB: regulation by distinct protein subunits. Biochim. Biophys. Acta. 1077:1991;63-80.
3. Baeuerle P.A., Henkel T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
4. Bales K.R., Du Y., Dodel R.C., Yan G.-M., Hamilton-Byrd E., Paul S.M. The NF-κB/Rel family of proteins mediates Aβ-induced neurotoxicity and glial activation. Mol. Brain Res. 57:1998;63-72.
5. 2+ accumulation. Proc. Natl. Acad. Sci. U.S.A. 92:1995;9328-9332.
6. Campbell I.L., Eddleston M., Kemper P., Oldstone M.B.A., Hobbs M.V. Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie. J. Virol. 68:1994;2383-2387.
7. Carp R.I., Callahan S.M. Variations in the characteristics of 10-mouse passaged scrapie lines derived from five scrapie positive sheep. J. Gen. Virol. 72:1991;293-298.
8. Carp R.I., Ye X., Kascsak R.J., Rubenstein R. The nature of the scrapie agent. Biological characteristics of scrapie in different scrapie strain-host combinations. Ann. N.Y. Acad. Sci. 724:1994;221-234.
9. Chao C.C., Hu S., Sheng W.S., Bu D., Bukrinsky M.I., Peterson P.K. Cytokine-stimulated astrocytes damage human neurons via nitric oxide mechanism. Glia. 16:1996;276-284.
10. Chao C.C., Lokensgard J.R., Sheng W.S., Hu S., Peterson P.K. IL-1-induced iNOS expression in human astrocytes via NF-κB. NeuroReport. 8:1997;3163-3166.
11. Choi J.H., Yu B.P. Brain synaptosomal aging: free radicals and membrane fluidity. Free Radical Biol. Med. 18:1995;133-139.
12. Choi S.I., Ju W.K., Choi E.K., Kim J., Lea H.Z., Carp R.I., Wisniewski H.M., Kim Y.S. Mitochondrial dysfunction induced by oxidative stress in the brains of hamsters infected with the 263 K scrapie agent. Acta Neuropathol. (Berlin). 96:1998;279-286.
13. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 62:1987;156-159.
14. DeArmond S.J., Prusiner S.B. Etiology and pathogenesis of prion diseases. Am. J. Pathol. 146:1995;785-811.
15. Diedrich J.F., Bendheim P.E., Kim Y.S., Carp R.I., Haase A.T. Scrapie-associated prion protein accumulates in astrocytes during scrapie infection. Proc. Natl. Acad. Sci. U.S.A. 88:1991;375-379.
16. Diedrich J.F., Minnigan H., Carp R.I., Whitaker J.N., Race R., Frey W. II, Haase A.T. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression apolipoprotein E and cathepsin D in astrocytes. J. Gen. Virol. 65:1991;4759-4768.
17. Florio T., Grimaldi M., Scorziello A., Salmona M., Bugiani O., Tagliavini F., Forloni G., Schettini G. Intracellular calcium rise through L-type calcium channels, as molecular mechanism for prion protein fragment 106-126-induced astroglial proliferation. Biochem. Biophys. Res. Commun. 228:1996;397-405.
18. Forloni G., Del Bo R., Angeretti N., Chiesa R., Smiroldo S., Doni R., Ghibaudi E., Salmona M., Porro M., Verga L. A neurotoxic prion protein fragment induces rat astroglial proliferation and hypertrophy. Eur. J. Neurosci. 6:1994;1415-1422.
19. Forloni G., Mangiarotti F., Angeretti N., Lucca E.De., Simoni M.G. Beta-amyloid fragment potentiates IL-6 and TNF-alpha secretion by LPS in astrocytes but not in microglia. Cytokine. 9:1997;759-762.
20. Gajdusek D.C. Unconventional viruses and the origin and disappearance of kuru. Science. 197:1977;943-960.
21. Gatti S., Bartfai T. Induction of tumor necrosis factor-α mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. Brain Res. 524:1993;291-294.
22. Goodman Y., Mattson M.P. Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid beta-peptide toxicity. J. Neurochem. 66:1996;869-872.
23. Guiroy D.C., Wakayama I., Liberski P.P., Gajdusek D.C. Relationship of microglia and scrapie amyloid-immunoreactive plaques in kuru, Creutzfeldt-Jakob disease and Gerstmann-Sträussler syndrome. Acta Neuropathol. (Berlin). 87:1994;526-530.
24. Hogeboom G.H. Fractionation of cell components of animal tissues. Methods Enzymol. 1:1955;16-17.
25. Hsiao K., Prusiner S.B. Inherited human prion diseases. Neurology. 40:1991;1820-1827.
26. Hunot S., Brugg B., Ricard D., Michel P.P., Muriel M.P., Ruberg M., Faucheux B.A., Agid Y., Hirsch E.C. Nuclear translocation of NF-κB is increased in dopaminergic neurons of patients with Parkinson disease. Proc. Natl. Acad. Sci. U.S.A. 94:1997;7531-7536.
27. Ishii T., Haga S., Yagishita S., Tateishi J. The presence of complements in amyloid plaques of Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker disease. Appl. Pathol. 2:1984;370-379.
28. Jeffrey M., Goodsir C.M., Bruce M.E., McBride P.A., Farquhar C. Morphogenesis of amyloid plaques in 87V murine scrapie. Neuropathol. Appl. Neurobiol. 20:1994;535-542.
29. Jeffrey M., Goodsir C.M., Fowler N., Hope J., Bruce M.E., McBride P.A. Ultrastructural immuno-localization of synthetic prion protein peptide antibodies in 87V murine scrapie. Neurodegeneration. 5:1996;101-109.
30. Ju W.K., Park K.J., Choi E.K., Kim J., Carp R.I., Wisniewski H.M., Kim Y.S. Expression of inducible nitric oxide synthase in the brains of scrapie-infected mice. J. Neurovirol. 4:1998;445-450.
31. Kaltschmidt B., Baeuerle P.A., Kaltschmidt C. Potential involvement of the transcription factor NF-κB in neurological disorders. Mol. Aspects Med. 14:1993;171-190.
32. Kaltschmidt C., Kaltschmidt B., Neumann H., Wekerle H., Baeuerle P.A. Constitutive NF-κB activity in neurons. Mol. Cell. Biol. 14:1994;3981-3992.
33. Kaltschmidt B., Uherek M., Volk B., Baeuerle P.A., Kaltschmidt C. Transcription factor NF-κB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 94:1997;2642-2647.
34. Kim Y.S., Carp R.I., Callahan S.M., Wisniewski H.M. Incubation periods and histopathological changes in mice injected stereotaxically in different brain areas with the 87V scrapie strain. Acta Neuropathol. (Berlin). 80:1990;388-392.
35. Kitamura Y., Shimohama S., Ota T., Matsuoka Y., Nomura Y., Taniguchi T. Alteration of transcription factors NF-kappaB and STAT1 in Alzheimer's disease brains. Neurosci. Lett. 237:1997;17-20.
36. Kordek R., Nerurkar V.R., Liberski P.P., Isaacson S., Yanagihara R., Gajdusek D.C. Heightened expression of tumor necrosis factor alpha, interleukin 1 alpha, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob disease in mice. Proc. Natl. Acad. Sci. U.S.A. 93:1996;9754-9758.
37. Kossodo S.D., Grau G.E. Profiles of cytokine production in relation with susceptibility to cerebral malaria. J. Immunol. 151:1993;4811-4820.
38. LeBel C.P., Odunze I.N., Adams J.D. Jr., Bondy S.C. Perturbations in cerebral oxygen radical formation and membrane order following vitamin E deficiency. Biochem. Biophys. Res. Commun. 163:1989;860-866.
39. Lipton S.A. Janus faces of NF-κB: neurodestruction versus neuroprotection. Nat. Med. 3:1997;19-22.
40. Lossinsky A.S., Moretz R.C., Carp R.I., Wisniewski H.M. Ultrastructural observations of spinal cord lesions and blood-brain barrier changes in scrapie-infected mice. Acta Neuropathol. (Berlin). 73:1987;43-52.
41. Lowry O.H., Roseborough N.J., Farr L.A., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
42. Mattson M.P., Goodman Y., Luo H., Fu W., Furukawa K. Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49:1997;681-697.
43. McFarlin D.E., Raff M.C., Simpson E., Nehlsen S.H. Scrapie in immunologically deficient mice. Nature. 233:1971;336.
44. McGeer P.L., McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative disease. Brain Res. Rev. 21:1995;195-218.
45. Meyer R.K., McKinley M.P., Bowman K.A., Barry R.A., Prusiner S.B. Separation and properties of cellular and scrapie prion proteins. Proc. Natl. Acad. Sci. U.S.A. 83:1986;2310-2314.
46. Moynagh P.N., Williams D.C., O'Neill L.A.J. Interleukin-1 activates transcription factor NF-κB in glial cells. Biochem. J. 294:1993;343-347.
47. Mrak R.E., Griffin W.S.T. The role of chronic self-propagating glial responses in neurodegeneration: implications for long-lived survivors of human immunodeficiency virus. J. Neurovirol. 3:1997;241-246.
48. Mrak R.E., Sheng J.G., Griffin W.S.T. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum. Pathol. 26:1995;816-823.
49. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
50. O'Neill L.A.J., Kaltschmidt C. NF-κB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20:1997;252-258.
51. Ohlsson H., Edlund T. Sequence-specific interactions of nuclear factors with the insulin gene enhancer. Cell. 45:1986;35-44.
52. Pahl H.L., Baeuerle P.A. The ER-overload response: activation of NF-κB. Trends Biochem. Sci. 22:1997;63-67.
53. Perez P., Lira S.A., Bravo R. Overexpression of RelA in transgenic mouse thymocytes: specific increase in levels of the inhibitor protein IκBα Mol. Cell. Biol. 15:1995;3523-3530.
54. Prusiner S.B. Molecular biology of prion disease. Science. 252:1991;1515-1522.
55. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science. 216:1982;144-146.
56. Prusiner S.B., DeArmond S.J. Prion diseases and neurodegeneration. Annu. Rev. Neurosci. 17:1994;311-339.
57. Rizzardini M., Chiesa R., Angeretti N., Lucca E., Salmona M., Forloni G., Cantoni L. Prion protein fragment 106-126 differentially induces heme oxygenase-1 mRNA in cultured neurons and astroglial cells. J. Neurochem. 68:1997;715-720.
58. J. Sambrook, E.F. Fritsch, T. Maniatis (Eds.), Molecular Cloning: A Laboratory Manual, 2nd edn., Cold Spring Harbor Laboratory Press, New York, 1989, pp. 6.39-6.48.
59. Schipper H.M., Cisse F.S., Stopa E.G. Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann. Neurol. 37:1995;758-768.
60. Schreck R., Rieber P., Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:1991;2247-2258.
61. Sen R., Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 46:1986;705-716.
62. Siebenlist U., Franzoso G., Brown K. Structure, regulation and function of NF-κB. Annu. Rev. Cell. Biol. 10:1994;405-455.
63. Staal F.J., Roederer M., Herzenberg L.A. Intracellular thiols regulate activation of nuclear factor κB and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 87:1990;9943-9947.
64. Terai K., Matsuo A., McGeer P.L. Enhancement of immunoreactivity for NF-κB in the hippocampal formation and cerebral cortex of Alzheimer's disease. Brain Res. 735:1996;159-168.
65. Terai K., Matsuo A., McGeer E.G., McGeer P.L. Enhancement of immunoreactivity for NF-κB in human cerebral infarction. Brain Res. 739:1996;343-349.
66. Williams A.E., Van Dam A.-M., Man-A-Hing W.K.H., Berkenbosch F., Eikelenboom P., Fraser H. Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice. Brain Res. 654:1994;200-206.
67. Williams A., Van Dam A.-M., Ritchie D., Eikelenboom P., Fraser H. Immunocytochemical appearance of cytokines, prostaglandin E2 and lipocortin-1 in the CNS during the incubation period of murine scrapie correlates with progressive PrP accumulations. Brain Res. 754:1997;171-180.
68. Wisniewski H.M., Wegiel J. Alzheimer's disease neuropathology. Current status of interpretation of lesion development. Ann. N.Y. Acad. Sci. 673:1992;270-284.
69. Yan S.D., Yan S.F., Chen X., Fu J., Chen M., Kuppusamy P., Smith M.A., Perry G., Godman G.C., Nawroth P., Zweier J.L., Stern D. Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nat. Med. 1:1995;693-699.
70. Yun S.W., Choi E.K., Ju W.K., Ann M.S., Carp R.I., Wisniewski H.M., Kim Y.S. Extensive degeneration of catecholaminergic neurons to scrapie agent 87V in the brains of IM mice. Mol. Chem. Neuropathol. 34:1998;121-132.